Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05902663 · ClinicalTrials.gov registry record

Natural History of Netherton Syndrome

A clinical trial, sponsored by Boehringer Ingelheim.

Terminated
Registry status
4
Enrollment target

NCT05902663 is a clinical trial that was terminated before completion, run by Boehringer Ingelheim. The registered enrollment target is 4 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05902663 was terminated before completion, sponsored by Boehringer Ingelheim.

TERMINATED
Registry status
4 participants
Enrollment target

Study Summary

The goal of this non-interventional study (NIS) is to collect real-world data to describe the natural history of Netherton Syndrome (NS).

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2024-10-09
Est. Completion 2025-03-31

Sponsor

Boehringer Ingelheim

515 total trials

What the Registry Record Tells You About NCT05902663

The ClinicalTrials.gov registry entry for NCT05902663 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boehringer Ingelheim, which has 515 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT05902663 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05902663 about?

NCT05902663 is a clinical study titled "Natural History of Netherton Syndrome". The goal of this non-interventional study (NIS) is to collect real-world data to describe the natural history of Netherton Syndrome (NS).

What is the current status of trial NCT05902663?

This trial is currently terminated. The enrollment target is 4 participants. The study started on 2024-10-09. Estimated completion is 2025-03-31.

Who is sponsoring clinical trial NCT05902663?

This trial is sponsored by Boehringer Ingelheim, which has 515 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.